Latest Articles

Publication Date
All News Scientific
Landmark endometriosis report promises major overhaul in treatment and awareness in South Australia - Glam Adelaide

Landmark endometriosis report promises major overhaul in treatment and awareness in South Australia Glam Adelaide

Published: March 20, 2025, 1:34 a.m.
Read Full Article
Rachel spends $400 a month on a disease affecting 830,000 Aussies. Treatment just got cheaper for some - 9News

Rachel spends $400 a month on a disease affecting 830,000 Aussies. Treatment just got cheaper for some 9News

Published: March 19, 2025, 10:55 p.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - The Malaysian Reserve

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy The Malaysian …

Published: March 19, 2025, 10:53 p.m.
Read Full Article
More affordable contraceptive, endometriosis and IVF treatment welcomed - ANMJ

More affordable contraceptive, endometriosis and IVF treatment welcomed ANMJ

Published: March 19, 2025, 12:34 p.m.
Read Full Article
Better endometriosis treatments may lie in migraine medications - Boston Children's Discoveries

Better endometriosis treatments may lie in migraine medications Boston Children's Discoveries

Published: March 19, 2025, 11:30 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Weekly Voice

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Weekly Voice

Published: March 19, 2025, 11:20 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Canada Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Canada …

Published: March 19, 2025, 11 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Finance

Published: March 19, 2025, 11 a.m.
Read Full Article
New possible stroke treatment identified by scientists in newly released study - Daily Record

New possible stroke treatment identified by scientists in newly released study Daily Record

Published: March 18, 2025, 7:17 p.m.
Read Full Article
In-Depth Endometriosis Treatment Market Analysis: Size, Share, and Growth Projections by 2032 - Newstrail

In-Depth Endometriosis Treatment Market Analysis: Size, Share, and Growth Projections by 2032 Newstrail

Published: March 18, 2025, 10:05 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!